Weight Loss Surgery Increases Kidney Transplant Rates in Patients With Renal Failure and Obesity
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00179906%3A_____%2F24%3A10480004" target="_blank" >RIV/00179906:_____/24:10480004 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11150/24:10480004
Result on the web
<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=bQdm_o94Z9" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=bQdm_o94Z9</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.mayocp.2024.01.017" target="_blank" >10.1016/j.mayocp.2024.01.017</a>
Alternative languages
Result language
angličtina
Original language name
Weight Loss Surgery Increases Kidney Transplant Rates in Patients With Renal Failure and Obesity
Original language description
Objective: To describe the outcomes of kidney transplant (KT) candidates with obesity undergoing sleeve gastrectomy (SG) to meet the criteria for KT.Methods: Retrospective analysis was conducted of electronic medical records of KT candidates with obesity (body mass index >35 kg/m2) who underwent SG in our institution. Weight loss, adverse health events, and the listing and transplant rates were abstracted and compared with the nonsurgical cohort.Results: The SG was performed in 54 patients; 50 patients did not have surgery. Baseline demographic characteristics were comparable at the time of evaluation. Mean body mass index SD of the SG group was 41.73.6 kg/m2 at baseline (vs 41.54.3 kg/m2 for nonsurgical controls); at 2 and12 months after SG, it was 36.44.1 kg/m2 and 32.64.0 kg/m2 (P<.01 for both). In the median follow-up time of 15.5 months (interquartile range, 6.4 to 23.9 months), SG was followed by activelisting (37/54 people), and 20 of 54 received KT during a median follow-up time of 20.9 months (interquartile range, 14.7 to 28.3 months) after SG. In contrast, 14 of 50 patients in the nonsurgical cohort were listed, and 5 received a KT (P<.01). Three patients (5.6%) experienced surgical complications. There was no difference in overall hospitalization rates and adverse health outcomes, but the SG cohort experienced a higher risk of clinically significant functional decline.Conclusion: In KT candidates with obesity, SG appears to be effective, with 37% of patients undergoing KT during the next 18 months (P<.01). Further research is needed to confirm and to improve the safety and efficacy of SG for patients with obesity seeking a KT.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30217 - Urology and nephrology
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2024
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Mayo Clinic Proceedings
ISSN
0025-6196
e-ISSN
1942-5546
Volume of the periodical
99
Issue of the periodical within the volume
5
Country of publishing house
US - UNITED STATES
Number of pages
11
Pages from-to
705-715
UT code for WoS article
001240052400001
EID of the result in the Scopus database
2-s2.0-85191182142